NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘biolimus-eluting biodegradable-polymer-coated stent’

RSS

January 26th, 2015

Selections from Richard Lehman’s Literature Review: January 26th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include dietary sodium content, mortality, and CVD risk in older adults, the ROX CONTROL HTN study, and more.

Categories: General
Tags: acute myocardial infarction, biolimus-eluting biodegradable-polymer-coated stent, cardiovascular risk, central arteriovenous anastomosis, dietary sodium, Elecsys Troponin T high-sensitive assay, high-sensitivity cardiac troponin, mortality, myocardial infarction, older patients, uncontrolled hypertension, women, zotarolimus-eluting durable-polymer-coated stent


  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Seeing the Left Main Coronary Artery Clearly — Is IVUS Always Necessary? June 11, 2026
      Treatment of the left main coronary artery with percutaneous coronary intervention (PCI) in the absence of previous surgical revascularization, also referred to as an unprotected left main coronary artery PCI, is one of the riskier tasks that interventional cardiologists are asked to perform. Stent implantation in the left main coronary...
    • IVUS — A Zigzag Path to Success June 11, 2026
      The use of intravascular ultrasound (IVUS) imaging for assessment of the coronary arteries has an almost 40-year history. In an editorial comment on an early ex vivo assessment of the accuracy of IVUS in evaluating human coronary arteries, Yock and Linker1 posed three questions that remain relevant today:...
    • Prescription without Precision — Dangers of Dosing on the Basis of Race as Biology June 11, 2026
      Despite recognition that racial and ethnic categories are poor proxies for genetic diversity, race is still used to guide pharmaceutical use, posing risks of ineffectively low or dangerously high dosing.
    • Case 16-2026: A 14-Year-Old Girl with Hypertension June 11, 2026
      A 14-year-old girl was admitted to the hospital because of hypertension and headache. She had hypokalemia, an elevated blood level of C-reactive protein, and an elevated erythrocyte sedimentation rate. A diagnosis was made.
    • Antidotes for Anticoagulation Reversal June 11, 2026
      The authors review current strategies for anticoagulation reversal in major bleeding events or urgent surgery as well as specific antidotes, limits of available evidence, thrombotic risks, unmet therapeutic needs, and ongoing research.
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |